The article discusses the establishment of the Cancer Screening Research Network by the U.S. National Institutes of Health (NIH). This…
Browsing: Liquid Biopsy
Getlabs, a leader in at-home diagnostics, has announced the addition of GRAIL’s GalleriⓇ multi-cancer early detection test to its suite…
Healthcare services company Curative Insurance Company and GRAIL, a healthcare company whose mission is to detect cancer early when it…
Delfi Diagnostics has put forward a new cancer monitoring test that searches the blood for broken pieces of tumor DNA,…
A phase 2/phase 3 clinical trial investigating the efficacy of using circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy in…
At the Gastrointestinal Cancers Symposium in San Francisco, two separate studies presented mixed results regarding the use of liquid biopsy…
Scientists have developed a groundbreaking test that can detect 18 early-stage cancers, potentially representing a significant advancement in medical diagnostics.…
PanGIA Biotech, a US-based biotechnology company, is finalizing a three-year, prospective, multicenter clinical study on prostate cancer liquid biopsy and…
Geneoscopy and Adiso Therapeutics have entered into a strategic collaboration to use Geneoscopy’s stool-based transcriptome platform in a Phase II…
Mainz Biomed N.V., a molecular genetics diagnostic company, has announced significant topline results from its eAArly DETECT U.S. clinical study.…